Natural Product: NPC10232

Natural Product IDNPC10232
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Strophanthidol
IUPAC Name 3-[(3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10-(hydroxymethyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1628279
PubChem CID 258412
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001125] Steroid lactones
          • [CHEMONTID:0001555] Cardenolides and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey ZNDMLUUNNNHNKC-HZXDTFASSA-N
Standard InCHI InChI=1S/C23H34O6/c1-20-6-3-17-18(4-8-22(27)11-15(25)2-7-21(17,22)13-24)23(20,28)9-5-16(20)14-10-19(26)29-12-14/h10,15-18,24-25,27-28H,2-9,11-13H2,1H3/t15-,16+,17-,18+,20+,21-,22-,23-/m0/s1
SMILES C[C@@]12CC[C@H]3[C@@H](CC[C@@]4(C[C@H](CC[C@]34CO)O)O)[C@]2(CC[C@@H]1C1=CC(=O)OC1)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   406.24 Volume:   411.05
?
Van der Waals volume.
Dense:   0.988 LogP:   0.763
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.433
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.975
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   26.0
TPSA:   107.22
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   4.0 Rings:   5.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.52 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.838 Fsp3:   0.87
MCE-18:   93.628
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.36 Fluc inhibitor:   0.08
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.013
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.274 Promiscuous compounds:   0.812

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.96 MDCK Permeability:   -4.761
Pgp-inhibitor:   0.002 Pgp-substrate:   0.983
PAMPA:   0.985
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.004
20% Bioavailability (F20%):   0.896 30% Bioavailability (F30%):   0.707
50% Bioavailability (F50%):   0.961

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.388 MRP1:   0.935
Plasma Protein Binding (PPB):   58.803% Volume Distribution (VD):   -0.11
Fu: 44.811%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.97
OATP1B3 inhibitor:   0.946 BCRP inhibitor:   0.004
BSEP inhibitor:   0.575

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.318 CYP3A4-substrate:   0.001
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.526
HLM stability:   0.007
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.137 Half-life (T1/2):  3.316

ADMET: Toxicity

hERG Blockers:  0.052 hERG Blockers (10um):  0.207
Human Hepatotoxicity (H-HT):  0.828 Drug-induced Liver Injury (DILI):  0.097
AMES Toxicity:  0.646 Rat Oral Acute Toxicity:  0.553
Maximum Recommended Daily Dose:  0.993 Skin Sensitization:  1.0
Carcinogencity:  0.99 Eye Corrosion:  0.0
Eye Irritation:  0.161 Respiratory Toxicity:  0.86
Drug-induced Neurotoxicity:  0.07 Ototoxicity:  0.601
Hematotoxicity:  0.373 Drug-induced Nephrotoxicity:  0.97
Genotoxicity:  0.81 RPMI-8226 Immunitoxicity:  0.262
A549 Cytotoxicity:  0.676 Hek293 Cytotoxicity:  0.861
BCF:   0.396
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.089
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.616
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.658
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8369 Antiaris toxicaria Species Moraceae Eukaryota n.a. n.a. n.a. PMID[20553004]
NPO8369 Antiaris toxicaria Species Moraceae Eukaryota latex Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Yunnan Province, China 2011-Mar PMID[24033101]
NPO8369 Antiaris toxicaria Species Moraceae Eukaryota trunk bark Yunnan, China n.a. PMID[24582402]
NPO8369 Antiaris toxicaria Species Moraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8369 Antiaris toxicaria Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8369 Antiaris toxicaria Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8369 Antiaris toxicaria Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT367 Cell line MDA-N Homo sapiens GI50 n.a. 2985.38 nM PMID[21565516]
NPT368 Cell line SN12C Homo sapiens GI50 n.a. 3467.37 nM PMID[20192247]
NPT370 Cell line NCI-H23 Homo sapiens GI50 n.a. 1475.71 nM PMID[17502416]
NPT371 Cell line UO-31 Homo sapiens GI50 n.a. 1901.08 nM PMID[26231157]
NPT369 Cell line ACHN Homo sapiens GI50 n.a. 466.66 nM PMID[23294829]
NPT116 Cell line HL-60 Homo sapiens GI50 n.a. 1644.37 nM PubChem BioAssay data set
NPT372 Cell line HOP-92 Homo sapiens GI50 n.a. 2779.71 nM PubChem BioAssay data set
NPT90 Cell line DU-145 Homo sapiens GI50 n.a. 1355.19 nM PMID[21174408]
NPT374 Cell line SF-539 Homo sapiens GI50 n.a. 1150.8 nM PMID[17190444]
NPT375 Cell line Malme-3M Homo sapiens GI50 n.a. 2208.0 nM PMID[24219991]
NPT373 Cell line SK-MEL-5 Homo sapiens GI50 n.a. 979.49 nM PMID[25798528]
NPT111 Cell line K562 Homo sapiens GI50 n.a. 2213.09 nM PMID[18529046]
NPT376 Cell line A498 Homo sapiens GI50 n.a. 1606.94 nM PubChem BioAssay data set
NPT377 Cell line OVCAR-3 Homo sapiens GI50 n.a. 993.12 nM DrugMatrix in vitro pharmacology data
NPT112 Cell line MOLT-4 Homo sapiens GI50 n.a. 225.42 nM DrugMatrix in vitro pharmacology data
NPT379 Cell line HOP-62 Homo sapiens GI50 n.a. 1355.19 nM PMID[23153200]
NPT380 Cell line U-251 Homo sapiens GI50 n.a. 2703.96 nM PMID[22652254]
NPT378 Cell line NCI/ADR-RES Homo sapiens GI50 n.a. 1510.08 nM DOI[10.1016/S0960-894X(01)80522-9]
NPT382 Cell line OVCAR-5 Homo sapiens GI50 n.a. 3069.02 nM PMID[18650093]
NPT381 Cell line OVCAR-8 Homo sapiens GI50 n.a. 1766.04 nM PMID[22137458]
NPT383 Cell line SNB-19 Homo sapiens GI50 n.a. 5942.92 nM PMID[25695368]
NPT385 Cell line SR Homo sapiens GI50 n.a. 860.99 nM PMID[9599250]
NPT82 Cell line MDA-MB-231 Homo sapiens GI50 n.a. 8452.79 nM DOI[10.1007/s00044-010-9338-x]
NPT323 Cell line SW-620 Homo sapiens GI50 n.a. 2365.92 nM PMID[25427242]
NPT384 Cell line TK-10 Homo sapiens GI50 n.a. 1517.05 nM PMID[20022146]
NPT455 Cell line NCI-H522 Homo sapiens GI50 n.a. 446.68 nM DrugMatrix in vivo data: Hematology
NPT387 Cell line M14 Homo sapiens GI50 n.a. 3006.08 nM DOI[10.6019/CHEMBL1201861]
NPT386 Cell line KM12 Homo sapiens GI50 n.a. 3664.38 nM PMID[12141859]
NPT389 Cell line RPMI-8226 Homo sapiens GI50 n.a. 1949.84 nM PMID[18640837]
NPT388 Cell line NCI-H322M Homo sapiens GI50 n.a. 2864.18 nM PMID[1431945]
NPT456 Cell line OVCAR-4 Homo sapiens GI50 n.a. 1124.6 nM PMID[18281952]
NPT457 Cell line BT-549 Homo sapiens GI50 n.a. 1510.08 nM PubChem BioAssay data set
NPT390 Cell line LOX IMVI Homo sapiens GI50 n.a. 2013.72 nM PMID[18341287]
NPT147 Cell line SK-MEL-2 Homo sapiens GI50 n.a. 2500.35 nM DOI[10.6019/CHEMBL1201861]
NPT81 Cell line A549 Homo sapiens GI50 n.a. 452.9 nM PMID[18821798]
NPT391 Cell line HCC 2998 Homo sapiens GI50 n.a. 22855.99 nM PMID[19318257]
NPT392 Cell line SNB-75 Homo sapiens GI50 n.a. 4017.91 nM PMID[8759161]
NPT148 Cell line HCT-15 Homo sapiens GI50 n.a. 1995.26 nM DrugMatrix in vivo data: Hematology
NPT395 Cell line SF-268 Homo sapiens GI50 n.a. 981.75 nM DrugMatrix in vitro pharmacology data
NPT393 Cell line HCT-116 Homo sapiens GI50 n.a. 553.35 nM PMID[12105963]
NPT394 Cell line EKVX Homo sapiens GI50 n.a. 1393.16 nM PMID[16252924]
NPT306 Cell line PC-3 Homo sapiens GI50 n.a. 2004.47 nM PMID[15165138]
NPT146 Cell line SK-OV-3 Homo sapiens GI50 n.a. 2642.41 nM PMID[3236012]
NPT396 Cell line T47D Homo sapiens GI50 n.a. 3296.1 nM PMID[18725452]
NPT397 Cell line NCI-H460 Homo sapiens GI50 n.a. 430.53 nM PMID[22194678]
NPT398 Cell line UACC-62 Homo sapiens GI50 n.a. 3523.71 nM PMID[22931300]
NPT308 Cell line CAKI-1 Homo sapiens GI50 n.a. 494.31 nM PMID[22694318]
NPT400 Cell line MDA-MB-435 Homo sapiens GI50 n.a. 2570.4 nM PMID[19651908]
NPT399 Cell line SF-295 Homo sapiens GI50 n.a. 1205.04 nM PMID[12270177]
NPT458 Cell line IGROV-1 Homo sapiens GI50 n.a. 2792.54 nM PubChem BioAssay data set
NPT402 Cell line Hs-578T Homo sapiens GI50 n.a. 1462.18 nM PMID[23398362]
NPT403 Cell line UACC-257 Homo sapiens GI50 n.a. 2985.38 nM PMID[22850207]
NPT401 Cell line 786-0 Homo sapiens GI50 n.a. 1415.79 nM PMID[2157014]
NPT404 Cell line CCRF-CEM Homo sapiens GI50 n.a. 522.4 nM PMID[21890359]
NPT405 Cell line NCI-H226 Homo sapiens GI50 n.a. 4027.17 nM PMID[9748381]
NPT170 Cell line SK-MEL-28 Homo sapiens GI50 n.a. 4775.29 nM PMID[18993063]
NPT139 Cell line HT-29 Homo sapiens GI50 n.a. 1936.42 nM PMID[22304344]
NPT406 Cell line RXF 393 Homo sapiens GI50 n.a. 222.84 nM PMID[22548480]
NPT407 Cell line COLO 205 Homo sapiens GI50 n.a. 3732.5 nM PMID[22276851]
NPT147 Cell line SK-MEL-2 Homo sapiens ED50 = 0.57 ug ml-1 PMID[18077425]
NPT308 Cell line CAKI-1 Homo sapiens ED50 = 0.67 ug ml-1 PMID[18077425]
NPT309 Cell line 1A9 Homo sapiens ED50 = 0.66 ug ml-1 PMID[18077425]
NPT306 Cell line PC-3 Homo sapiens ED50 = 0.81 ug ml-1 PMID[18271551]
NPT83 Cell line MCF7 Homo sapiens ED50 = 0.69 ug ml-1 PMID[18271551]
NPT81 Cell line A549 Homo sapiens ED50 = 0.14 ug ml-1 PMID[18271551]
NPT91 Cell line KB Homo sapiens ED50 = 2.7 ug ml-1 PMID[18271551]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 1.25 uM PMID[20553004]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 0.3 uM PMID[20553004]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 205.0 % PMID[20553004]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 408.0 % PMID[20553004]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Ratio = 6.3 n.a. PMID[20553004]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Ratio = 65.0 n.a. PMID[20553004]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. ED50 = 6.4 ug ml-1 PMID[24582402]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. ED50 = 2.9 ug ml-1 PMID[24582402]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. ED50 = 3.0 ug ml-1 PMID[24582402]
NPT897 Others Monoclonal antibody (mAb) n.a. Relative Ki = 4.0 n.a. PMID[12109909]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC10232 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8276 Intermediate Similarity NPC97487
0.7869 Intermediate Similarity NPC72772
0.6769 Remote Similarity NPC222875
0.6769 Remote Similarity NPC25177
0.6533 Remote Similarity NPC243196
0.6462 Remote Similarity NPC268829
0.6462 Remote Similarity NPC295110
0.6447 Remote Similarity NPC146456
0.6184 Remote Similarity NPC157376
0.6184 Remote Similarity NPC142066
0.6184 Remote Similarity NPC603972
0.6119 Remote Similarity NPC480913
0.597 Remote Similarity NPC187302
0.5789 Remote Similarity NPC158344
0.5652 Remote Similarity NPC196931
0.5641 Remote Similarity NPC219085
0.5641 Remote Similarity NPC84987
0.5584 Remote Similarity NPC474418
0.5513 Remote Similarity NPC99728
0.5513 Remote Similarity NPC87250
0.5513 Remote Similarity NPC244402
0.5513 Remote Similarity NPC50305
0.5429 Remote Similarity NPC160583
0.5417 Remote Similarity NPC196471
0.5375 Remote Similarity NPC6108
0.5375 Remote Similarity NPC17896
0.5375 Remote Similarity NPC469755
0.5375 Remote Similarity NPC284406
0.5375 Remote Similarity NPC89514
0.5375 Remote Similarity NPC34390
0.5375 Remote Similarity NPC197707
0.5375 Remote Similarity NPC251866
0.5309 Remote Similarity NPC10823
0.5294 Remote Similarity NPC116683
0.5244 Remote Similarity NPC180079
0.5211 Remote Similarity NPC189588
0.5185 Remote Similarity NPC77299
0.5185 Remote Similarity NPC480906
0.5143 Remote Similarity NPC220217
0.5122 Remote Similarity NPC76572
0.5122 Remote Similarity NPC193382
0.5122 Remote Similarity NPC604978
0.5068 Remote Similarity NPC469794
0.5062 Remote Similarity NPC203862

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC10232 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5375 Remote Similarity NPD7319 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data